HUGEL, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 217,500 KRW | +4.82% |
|
+7.94% | +45.58% |
| May. 16 | Tranche Update on Hugel, Inc.'s Equity Buyback Plan announced on February 13, 2024. | CI |
| Mar. 27 | Hugel, Inc. announces an Equity Buyback for KRW 50,000 million worth of its shares. | CI |
Chart calendar Hugel, Inc.
517e3f9e2f5ecc8bd10596c4f6d2.e9hWODUjnK0RKHs_bSuIyNiVVT2z3PqZhX7PXIYKths.SPUQc1h1q_UnWAwJX3P4u6GhGAna6KDbxj28Jcpv_kI5uRJwbHnl-0VvSw~a69db2a2ca59585d9e8082dcab2c9361
Upcoming events on Hugel, Inc.
Past events on Hugel, Inc.
| 2024-05-15 | Non Deal Roadshow |
| 2024-05-13 | Non Deal Roadshow |
| 2024-05-09 | Samsung Global Investors Conference |
| 2024-05-09 02:30 am | Q1 2024 Earnings Call |
| 2024-05-08 | Q1 2024 Earnings Release |
| 2024-02-14 02:19 am | Q4 2023 Sales and Revenue Release |
| 2024-02-13 | Q4 2023 Earnings Release |
| 2023-11-15 | Non Deal Roadshow - Day 2 |
| 2023-11-14 | Non Deal Roadshow - Day 1 |
| 2023-11-13 08:00 am | Q3 2023 Earnings Release |
| 2023-11-12 | Q3 2023 Earnings Call |
| 2023-10-30 | KOSDAQ Global IR Conference |
| 2023-08-16 | Investor Meeting - Day 2 |
| 2023-08-15 | Investor Meeting - Day 1 |
| 2023-08-09 02:30 am | Q2 2023 Earnings Call |
| 2023-08-08 | Q2 2023 Earnings Release |
| 2023-05-24 | Samsung Securities Global Conference |
| 2023-05-15 | Roadshow |
| 2023-05-14 | Roadshow - Day 1 |
| 2023-05-10 02:30 am | Q1 2023 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Billions KRW | Released Forecast Spread | 205 206 -0.82% | 211 208 1.22% | 245 242 1.45% | 282 278 1.2% | 320 322 -0.79% | 370 |
|
EBITDA Billions KRW | Released Forecast Spread | 77,6 78,4 -1.03% | 88,8 86,1 3.06% | 111 109 1.83% | 115 109 6.1% | 132 127 3.72% | 159 |
|
EBIT Billions KRW | Released Forecast Spread | 68,1 69,8 -2.51% | 78,2 76,1 2.76% | 97,1 97,1 0% | 102 96,7 5.99% | 118 115 2.31% | 143 |
|
Earnings before Tax (EBT) Billions KRW | Released Forecast Spread | 69,7 74,4 -6.29% | 81,7 74,6 9.58% | 89,0 93,9 -5.21% | 66,5 104 -35.88% | 133 132 0.59% | 145 |
|
Net income Billions KRW | Released Forecast Spread | 44,6 51,9 -14.05% | 51,9 47,3 9.61% | 57,5 65,2 -11.72% | 57,7 71,5 -19.39% | 92,3 96,4 -4.23% | 102 |
|
EPS KRW | Released Forecast Spread | 3 532 3 823 -7.62% | 3 344 4 122 -18.87% | 4 658 5 229 -10.92% | 4 545 5 843 -22.21% | 7 934 7 915 0.24% | 8 509 |
| Announcement Date | 12/03/20 | 09/02/21 | 10/02/22 | 09/02/23 | 14/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Billions KRW | Released Forecast Spread | 64,9 63,5 2.12% | 67,4 69,0 -2.29% | 70,7 70,5 0.29% | 85,5 75,2 13.67% | 64,4 76,7 -16.01% | 81,6 77,5 5.23% | 84,8 81,0 4.78% | 88,9 91,7 -2.97% | 74,3 79,0 -5.91% | 93,8 | 101 | 104 | 108 | 113 |
|
EBITDA Billions KRW | Released Forecast Spread | 32,8 28,4 15.57% | 21,9 30,3 -27.8% | 31,4 30,5 2.89% | 37,7 27,8 35.56% | 40,3 38,5 4.78% | 27,8 28,5 -2.33% | 41,0 | 45,5 | 46,5 | |||||
|
EBIT Billions KRW | Released Forecast Spread | 25,0 24,0 4.32% | 22,3 24,3 -8.21% | 24,8 23,5 5.28% | 31,2 25,4 22.78% | 18,5 25,9 -28.57% | 28,0 23,4 19.42% | 34,6 26,3 31.63% | 36,8 33,3 10.54% | 24,0 26,8 -10.44% | 36,6 | 42,8 | 40,6 | 39,7 | 43,1 |
|
Earnings before Tax (EBT) Billions KRW | Released Forecast Spread | 22,1 24,0 -7.77% | 23,2 26,2 -11.6% | 31,9 26,8 19.19% | -12,6 28,2 -144.61% | 24,3 28,3 -14.21% | 30,9 25,3 22% | 53,7 28,9 85.64% | 24,0 32,6 -26.35% | 29,4 29,3 0.35% | 35,5 | 38,0 | 41,2 | 40,8 | 44,2 |
|
Net income Billions KRW | Released Forecast Spread | 15,0 14,1 6.11% | 14,8 18,3 -19.23% | 25,8 17,3 48.62% | 2,14 18,3 -88.26% | 16,4 19,2 -14.49% | 21,1 17,6 20.28% | 39,4 19,9 98.45% | 15,4 18,9 -18.19% | 20,8 22,3 -6.7% | 24,7 | 27,1 | 29,5 | 29,0 | 31,4 |
| Announcement Date | 11/05/22 | 10/08/22 | 10/11/22 | 09/02/23 | 10/05/23 | 09/08/23 | 13/11/23 | 14/02/24 | 09/05/24 | - | - | - | - | - |
| 2024-07-11 02:00 am | BONESUPPORT HOLDING AB: Q2 2024 Earnings Release |
| 2024-07-15 | SWEDISH ORPHAN BIOVITRUM AB: Q2 2024 Earnings Release |
| 2024-07-22 | BIOGEN INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 02:00 am | BIOGAIA AB: Q2 2024 Earnings Release |
| 2024-07-23 | SAMSUNG BIOLOGICS CO.,LTD.: Q2 2024 Earnings Release (Projected) |
| 2024-07-24 | PHARMA MAR, S.A.: Q2 2024 Earnings Release (Projected) |
| 2024-07-24 | GRIFOLS, S.A.: Q2 2024 Earnings Release (Projected) |
| 2024-07-25 01:00 am | UCB: Q2 2024 Earnings Release |
| 2024-07-25 | SK BIOSCIENCE CO.,LTD.: Q2 2024 Earnings Release (Projected) |
| 2024-07-29 | BIOMARIN PHARMACEUTICAL INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Hugel, Inc.
| 2024-05-23 05:43 am | CONCORD BIOTECH LIMITED: Q4 2024 Earnings Release |
| 2024-05-14 11:35 am | GRIFOLS, S.A.: Q1 2024 Earnings Release |
| 2024-05-12 | ALTEOGEN INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-09 | PHARMARESEARCH CO., LTD.: Q1 2024 Earnings Release |
| 2024-05-09 | MEDY-TOX INC.: Q1 2024 Earnings Release |
| 2024-05-09 04:05 pm | AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release |
| 2024-05-09 04:05 pm | ADMA BIOLOGICS, INC.: Q1 2024 Earnings Release |
| 2024-05-09 02:30 am | NXERA PHARMA CO., LTD.: Q1 2024 Earnings Release |
| 2024-05-08 | HUGEL, INC.: Q1 2024 Earnings Release |
| 2024-05-08 04:16 pm | CATALYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- A145020 Stock
- Calendar Hugel, Inc.
